Eye Imaging for the Study of Childhood Myopia

NCT07335146 | Recruiting

• 2 other identifiers: WS104452025-A00844-45
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Myopia (nearsightedness) is increasing worldwide and is becoming a serious public health problem. Studies estimate that by 2050, if no action is taken, almost half of the world's population will be myopic. About 10% of people could develop severe myopia, which increases the risk of serious eye problems such as retinal detachment, damage to the macula, or glaucoma. Children are particularly affected because myopia often worsens as they grow. Several treatments are now available to slow the progression of myopia in children, but these treatments are not equally effective for everyone. Some children respond better than others, and the reasons for these differences are not yet well understood. One possible explanation is that differences in eye anatomy may influence the effectiveness of a treatment. This suggests that myopia treatments may need to be tailored to each child. By studying the anatomy of the eye, researchers could improve and personalize myopia control strategies. The study entitled "Eye imaging for the study of childhood myopia" aims to better understand the structure of children's eyes. The study will collect clinical data, including images of the eye taken with MRI and measurements of the eye obtained using standard eye examination devices. The data will then be analyzed using image-processing and statistical methods to allow a detailed study of children's eye anatomy.

Conditions

Hyperopia and Myopia

Keywords

myopia; eye anatomy; ophthalmological measurements

Outcome Measures

Primary Outcomes (1)

• Eye anatomy

  This set of data will enable an in-depth study of the eye anatomy: MRI will provide anatomical characteristics of the eyeball and its surrounding tissues such as the optical nerve. Ophtalmic measurements will provide anatomical characteristics of the eye's refractive system, such as corneal pachymetry, with optimal geometric resolution. Thus, MRI images and ophtalmic measurements will be combined to study the overall eye anatomy. Period: From inclusion up to 3 months after inclusion

  From enrollment to 3 months after enrollment

Study Arms (1)

MRI and ophthalmological measurements

EXPERIMENTAL

All enrolled participants will undergo the same eye examinations such as head MRI and ophthalmological measurements

Device: Ophtalmic measurements to estimate geometrical distances; Device: MRI; Device: Ophtalmic measurements to measure wavefront aberrations

Interventions

Ophtalmic measurements to estimate geometrical distances DEVICE

Patients will undergo routine ophthalmic examinations, such as ocular biometry to estimate axial length and corneal topography. Anatomical characteristics will then be derived from the geometric measurements obtained from each device. All measurements are non-invasive and non-ionizing. They all involve conventional ophthalmic devices that are widely used in clinical settings.

MRI and ophthalmological measurements

MRI DEVICE

Participants will undergo Magnetic Resonance Imaging (MRI) to image their eyes. A head antenna will be used. All measurements are non-invasive.

MRI and ophthalmological measurements

Ophtalmic measurements to measure wavefront aberrations DEVICE

Patients will undergo ophthalmic measurements to assess ocular wavefront aberrations. These measurements will be performed using commercially available devices that are widely accepted in routine clinical practice. All procedures are non-invasive and non-ionizing.

MRI and ophthalmological measurements

Eligibility Criteria

• Age: 6 Years - 12 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Spherical equivalent under cycloplegia greater -6.5 D and less than 2 D
• Beneficiary of social security
• Written consent from both holders of parental authority (or from one in case of exclusive parental authority)

You may not qualify if:

• Declared neurological deficit, including history of epileptic pathology or sensory-motor coordination disorders, vestibular or cerebellar pathology (for example, balance disorders)
• Current or progressive pathology of the eyes or their appendages that may affect vision, other than myopia (examples: glaucoma, retinitis pigmentosa…)
• Declared aphakia or pseudophakia (intraocular implant)
• Ocular motility problem such as strabismus or nystagmus
• Contraindication to MRI (claustrophobia, implanted devices such as pacemaker, etc.)

Sponsors & Collaborators

• Essilor International: lead

Study Sites (1)

Hôpital Fondation Adolphe de Rothschild

Paris, 75019, France

RECRUITING

MeSH Terms

Conditions

Hyperopia; Myopia

Condition Hierarchy (Ancestors)

Refractive Errors; Eye Diseases

Central Study Contacts

Julien Savatosky, Doctor

CONTACT

00331 48 03 69 30; jsavatovsky@for.paris

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 5, 2026
• First Posted: January 13, 2026
• Study Start: February 18, 2026
• Primary Completion (Estimated): December 1, 2027
• Study Completion (Estimated): December 1, 2027
• Last Updated: March 30, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)